Table 2.
Baseline characteristics of inflammatory and damage markers and lipidomic profile.
| Overall | Placebo | Treatment | p-Value * | |
|---|---|---|---|---|
| Inflammatory and damage markers at baseline | ||||
| White blood cells (n × 109) | 4.96 ± 1.35 | 5.04 ± 1.47 | 4.88 ± 1.25 | 0.671 |
| Neutrophil (n × 109) | 2.58 ± 1.11 | 2.71 ± 1.39 | 2.45 ± 0.74 | 0.409 |
| Cortisol (nmol/L) | 22.36 ± 5.14 | 21.52 ± 5.50 | 23.19 ± 4.71 | 0.247 |
| IL-6 (pg/mL) | 2.49 ± 1.13 | 2.31 ± 0.66 | 2.66 ± 1.45 | 0.269 |
| CRP (mg/dL) | 0.16 ± 0.18 | 0.19 ± 0.26 | 0.14 ± 0.03 | 0.333 |
| CK (IU/L) | 233.77 ± 239.71 | 259.92 ± 321.55 | 207.62 ± 111.37 | 0.437 |
| Lipidomic profile at baseline | ||||
| ω-3 index (%) | 2.33 ± 0.81 | 2.38 ± 0.89 | 2.28 ± 0.73 | 0.669 |
| EPA (%) | 0.36 ± 0.13 | 0.34 ± 0.13 | 0.38 ± 0.14 | 0.329 |
| DHA (%) | 1.97 ± 0.72 | 2.04 ± 0.80 | 1.90 ± 0.64 | 0.509 |
| AA (%) | 8.36 ± 1.64 | 8.32 ± 1.80 | 8.40 ± 1.51 | 0.878 |
| AA/EPA ratio | 25.74 ± 8.96 | 26.80 ± 9.50 | 24.68 ± 8.45 | 0.399 |
* p-value refers to the comparison between the two arms. Results were shown as mean ± SD or percentage (%). AA = arachidonic acid; CK = creatine phosphokinase; CRP = C-protein reactive; DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; IL-6 = interleukin 6; IU = international units.